Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3428 studies found for:    (prostate cancer) [CONDITION]
Show Display Options
Rank Status Study
1 Not yet recruiting Neoadjuvant And Adjuvant Abiraterone Acetate + Aptilutamide Prostate Cancer Undergoing Prostatectomy
Condition: Prostate Cancer
Interventions: Drug: Aptilutamide;   Drug: Leuprolide;   Drug: Prednisone;   Drug: Abiraterone Acetate;   Procedure: Radical Prostatectomy;   Other: Observation-Post RP
2 Not yet recruiting A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: LY2452473;   Drug: Placebo
3 Recruiting Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy
Condition: Prostate Cancer
Intervention:
4 Recruiting Metformin for Rising PSA Remote Trial
Condition: Prostate Cancer
Intervention: Drug: Metformin
5 Recruiting MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy
Condition: Prostate Cancer
Interventions: Radiation: LEAD RT;   Radiation: HEIGHT RT;   Behavioral: International Prostate Symptom Score;   Behavioral: Memorial Anxiety Scale for Prostate Cancer patients;   Behavioral: Expanded Prostate Cancer Index Composite-Short Form 12
6 Completed PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study
Condition: Prostate Cancer
Intervention:
7 Unknown  Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in Men
Condition: Prostate Cancer
Intervention: Other: Magnetic Nanoparticle Injection
8 Enrolling by invitation A Pilot Study of the Feasibility of Chronic Cavernous Nerve Stimulation to Promote Regeneration and Erectile Function
Condition: Prostate Cancer
Intervention: Device: Nerve Stimulation
9 Recruiting Evaluation of Diet and Exercise in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention:
10 Recruiting Early Changes In Multiparametric MRI In Prostate Cancer
Condition: Prostate Cancer
Interventions: Device: MRI;   Other: PSA Blood Test
11 Withdrawn Periperal Blood Lymphocytes During Prostate RT
Condition: Prostate Cancer
Intervention:
12 Withdrawn Study of Dasatinib, Androgen Deprivation Therapy and Radiation
Condition: Prostate Cancer
Intervention: Drug: Dasatinib
13 Completed A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate
Condition: Prostate Cancer
Interventions: Drug: AT13387;   Drug: abiraterone acetate;   Drug: Prednisone
14 Active, not recruiting Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate Cancer
Condition: Prostate Cancer
Intervention: Radiation: Radiotherapy with IMRT and CyberKnife Boost
15 Unknown  Oncological and Functional Outcomes After Radical Prostatectomy for Prostate Cancer: Comparing Open With Robot-assisted Surgery
Condition: Prostate Cancer
Intervention:
16 Completed Eating, Activity, and Stress Education
Condition: Prostate Cancer
Intervention: Behavioral: Lifestyle counseling
17 Completed Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study
Condition: Prostate Cancer
Intervention:
18 Completed Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Hyperpolarized Pyruvate (13C) injection
19 Completed A Study of IMC-3G3 in Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: IMC-3G3;   Drug: Mitoxantrone
20 Completed High Risk Prostate Cancer Prevention Study
Condition: Prostate Cancer
Intervention: Drug: finasteride

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.